Karen Dreesen is a seasoned professional in the pharmaceutical sector, currently serving as a QA Assurance de stérilité at LFB since July 2023, while also working as a consultant at Nalys since May 2022. Prior roles include positions at GSK, UCB, and MCA Belgium, where responsibilities ranged from QA Assurance de stérilité to Product & Process/Validation Coordination. Karen's earlier experience includes roles as a QA Operational and QA System Officer at DELPHARM DROGENBOS and an internship in Clinical Research at University College Cork. Academic qualifications include a Master's degree in Pharmaceutical Sciences and a Bachelor's degree in Pharmaceutical Sciences from Université catholique de Louvain, along with an Expert en études Cliniques certification from CEFOCHIM.